Henan Ancai Hi-TechCo.,Ltd. (600207.SH) elects director Xu Dongwei as chairman.
Ancaigaoke (600207.SH)announcement, the board of directors of the company agreed to elect director Xu Dongwei as the chairman of the company.
Henan Ancai Hi-TechCo.,Ltd. (600207.SH) announced that the Board of Directors has agreed to elect Director Xu Dongwei as the Chairman of the company. His term will start from the date of approval at the 21st meeting of the eighth Board of Directors and will end on the day the current Board of Directors term expires.
Related Articles
HPC HOLDINGS (01742) Announces Profit Growth, Expected Mid-term Net Profit Approximately 9.34 Million Singapore Dollars.
SIHUAN PHARM(00460): Xuan Bamboo Biotech (02575) completes the first patient enrollment in the Phase III clinical trial of Anantrezole Sodium for new indications for the eradication of Helicobacter pylori.
SSY Group (02005): Obtained the drug production registration approval for Methylphenidate Sulfate tablets (100mg and 50mg) from the National Medical Products Administration.
HPC HOLDINGS (01742) Announces Profit Growth, Expected Mid-term Net Profit Approximately 9.34 Million Singapore Dollars.
SIHUAN PHARM(00460): Xuan Bamboo Biotech (02575) completes the first patient enrollment in the Phase III clinical trial of Anantrezole Sodium for new indications for the eradication of Helicobacter pylori.
SSY Group (02005): Obtained the drug production registration approval for Methylphenidate Sulfate tablets (100mg and 50mg) from the National Medical Products Administration.
RECOMMEND
